Who Is the Most Profitable Company in Brain-Computer Interface Device Technology?

The core value of brain-computer interfaces lies in transcending the limitations of traditional limb- or language-based interaction, providing revolutionary solutions for healthcare, technology, and daily life.

Brain-Computer Interface Company Neuralink Will Begin “Mass Production” of Brain-Computer Interface Devices in 2026, While Simultaneously Advancing a Highly Streamlined, Nearly Fully Automated Surgical Procedure; the Most Critical Breakthrough Is That the Electrode Wires in the Device Will Pass Directly Through the Dura Mater Without Requiring Its Removal.

Brain-Computer Interface · Breakdown of Each Segment in the Device Technology Industry Chain

Invasive (Implantable): Electrodes are implanted into the cerebral cortex, offering high bandwidth and high resolution (up to 1024 channels), for medical applications such as paralysis and epilepsy.

Representative devices: Neuralink N1 (coin-sized, 1024-channel flexible electrode), BrainCo flexible electrode array. Key equipment: implantable electrodes, specialized chips, surgical robots.

Semi-invasive (ECoG/SEEG): Electrodes are placed between the skull and the dura mater, balancing signal quality with safety and causing less trauma than invasive methods.

Representative devices: Boreas NEO, "Beinao No. 1". Key equipment: ECoG electrodes, semi-implantable signal processors.

Non-invasive (EEG/fNIRS): Scalp acquisition, non-invasive, low-cost, easy to popularize, with lower signal resolution.

Representative devices: Polysomnography (PSG) monitors, consumer-grade EEG headbands. Key devices: Dry/gel electrodes, portable signal processing units, multimodal fusion chips.

Brain-Computer Interface · Profitability of Enterprises in the Device Technology Industry Chain

A company’s profitability is typically reflected by the magnitude and level of its earnings over a given period. An analysis of profitability constitutes an in-depth examination of the company’s profit margins.

This article is part of the Corporate Value series focusing on [Profitability]. It selects 24 companies in the brain-computer interface (BCI) device technology industry chain as research samples, using return on equity (ROE), gross profit margin, and net profit margin as evaluation metrics.

Data is based on historical records and does not represent future trends; it is for static analysis only and does not constitute investment advice.

10 Sanbo Brain Hospital

Industry Segment: Medical Services

Profitability: Return on Equity (ROE) 4.51%, Gross Profit Margin 23.49%, Net Profit Margin 8.09%

Performance Forecast: No institutional performance forecasts have been issued for the current year.

Core Products: Revenue from medical services is the primary source of income, accounting for 76.33% of total revenue, with a gross profit margin of 27.09%.

Company Highlights: As an academic medical institution integrating medical care, education, and research, Sanbo Brain Hospital continues to focus on the application and development of brain-computer interface technology in the medical field.

9. Rigol Technologies

Industry Subsector: Instruments and Meters

Profitability: Return on Equity (ROE) 3.11%, Gross Profit Margin 59.14%, Net Profit Margin 11.90%

Performance Forecast: ROE has declined consecutively over the past three years to 3.11%, with the latest mean forecast at 3.12%.

Main Products: Electronic test and measurement instruments are the primary source of revenue, accounting for 81.70% of total revenue, with a gross profit margin of 56.64%.

Company Highlights: Rigol Technologies’ core business is general-purpose electronic test and measurement. The company’s digital oscilloscope products can be used in certain scenarios for electroencephalogram (EEG) monitoring.

8. Hanwei Technology

Industry Subsector: Instruments and Meters

Profitability: Return on Equity (ROE) 2.70%, Gross Profit Margin 29.85%, Net Profit Margin 2.41%

Performance Forecast: ROE has declined consecutively over the past three years to 2.70%, with the latest mean forecast at 5.65%.

Main Products: Smart meters are the primary source of revenue, accounting for 44.67% of total revenue, with a gross profit margin of 40.38%.

Company Highlights: Hanwei Technology's flexible sensors can be applied in the non-invasive acquisition of physiological electrical signals and other information from the brain.

No. 7 Xiangyu Medical

Industry Segmentation:Medical Devices

Profitability: Return on Equity (ROE) 5.02%, Gross Profit Margin 67.42%, Net Profit Margin 13.83%

Performance Forecast: ROE has fluctuated between 5% and 12% over the past three years, with the latest mean forecast at 5.00%.

Main Products: Rehabilitation and physiotherapy equipment constitutes the primary source of revenue, accounting for 67.79% of total revenue, with a gross profit margin of 67.83%.

Company Highlights: Xiangyu Medical focuses on five major R&D directions, covering EEG acquisition devices, brain-controlled products, lifestyle scenario-based products, self-developed algorithms, and cerebral biomedicine.

6. Keeson Technology

Industry Segment: Finished Home Furnishings

Profitability: Return on Equity (ROE) 5.01%, Gross Profit Margin 34.85%, Net Profit Margin 5.23%

Performance Forecast: ROE peaked at 6.44% over the past three years, with the latest mean forecast at 5.70%.

Main Products: Smart electric beds are the primary source of revenue, accounting for 80.92% of total revenue, with a gross profit margin of 34.29%.

Company Highlights: Keeson Technology’s core business is smart electric beds. The company’s bidirectional brain-computer interaction technology can be applied in the smart home sector.

5. ZKTeco

Industry Subsector: Security Equipment

Profitability: Return on Equity (ROE) 5.60%, Gross Profit Margin 49.37%, Net Profit Margin 10.07%

Performance Forecast: ROE has declined consecutively over the past three years to 5.60%, with the latest mean forecast at 6.52%.

Main Products: Smart Space is the primary source of revenue, accounting for 75.32% of total revenue, with a gross profit margin of 48.01%.

Company Highlights: The joint venture established by ZKTeco and NeuroSky primarily focuses on the research and development of next-generation edge brain-computer interface (BCI) algorithm chips, as well as advancing hybrid biometrics and collaborative analysis of brain signals.

#4 Shinva Medical

Industry Subsector: Medical Devices

Profitability: Return on Equity (ROE) 9.29%, Gross Profit Margin 26.06%, Net Profit Margin 6.90%

Performance Forecast: ROE has declined consecutively over the past three years to 9.29%, with the latest mean forecast at 7.71%.

Core Products: Medical device manufacturing is the primary source of revenue, accounting for 37.27% of total revenue, with a gross profit margin of 42.17%.

Company Highlights: Xinhua Medical has initiated the development of the first-generation prototype combining brain-computer interfaces with rehabilitation equipment, and will further expand its practical applications in rehabilitation assessment and training.

3. Intretech

Industry Subsector: Consumer Electronics Components and Assembly

Profitability: Return on Equity (ROE) 5.21%, Gross Profit Margin 28.36%, Net Profit Margin 7.47%

Performance Forecast: ROE has declined consecutively over the past three years to 5.21%, with the latest average forecast at 7.53%

Main Products: Intelligent control components are the primary source of revenue, accounting for 32.05% of total revenue, with a gross profit margin of 23.75%.

Company Highlights: In the field of brain-computer interfaces, Intretech has already collaborated with customer InteraXon to develop a wearable EEG monitoring product.

No. 2 Lens Technology

Industry Subsector: Consumer Electronics Components and Assembly

Profitability: Return on Equity (ROE) 7.64%, Gross Profit Margin 15.89%, Net Profit Margin 5.26%

Performance Forecast: ROE has risen consecutively over the past three years to 7.64%, with the latest mean forecast at 9.53%.

Main Products: Smartphones and computers are the primary source of revenue, accounting for 82.63% of total revenue, with a gross profit margin of 15.11%.

Company Highlights: Lens Technology enters the brain-computer interface sector through strategic investment, exclusive mass production, and technological synergy. It has established a core partnership with BrainCo, focusing on the deployment of non-invasive medical rehabilitation and embodied intelligence hardware.

No. 1 Redick

Industry Sub-sector: Tires and Wheels

Profitability: Return on Equity (ROE) 8.89%, Gross Profit Margin 31.61%, Net Profit Margin 16.24%

Performance Forecast: ROE has declined consecutively over the past three years to 8.89%, with the latest mean forecast at 10.67%.

Core Products: Wheel hub units are the primary source of revenue, accounting for 35.64% of total revenue, with a gross profit margin of 27.45%.

Company Highlights: Aoyi Technology, in which Leadik holds shares, is a leading domestic high-tech enterprise featuring two core underlying technologies: robotics and brain-computer interfaces.

       Original Title: Brain-Computer Interface · Device Technology, Which Company Is the Most Profitable?